When Statins Aren’t Enough: Expanding ASCVD Prevention: Brooklyn Hospital Only

April 17, 2026

Target Audience

All pharmacists

Learning Objectives

At the completion of this activity, the participant will be able to:

Describe the role of lipid-lowering therapy in the prevention of atherosclerotic cardiovascular disease (ASCVD)
List non-statin therapies available for ASCVD risk reduction
Identify key clinical evidence supporting the use of non-statin therapies
Compare apolipoprotein B (ApoB) with traditional lipid markers in cardiovascular risk assessment
Describe the role of ApoB in evaluating cardiovascular risk and informing treatment strategies

Course summary
Available credit: 
  • 1.00 ACPE
    The Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Course opens: 
04/17/2026
Course expires: 
12/15/2028
Event starts: 
04/17/2026 - 2:00pm EDT
Event ends: 
04/17/2026 - 3:00pm EDT
Cost:
$0.00
Add to calendar: 
Rating: 
0
ZOOM or Brooklyn Hospital
United States

Anna Sokolskaya

 

Resident

 

Pharmacy

 
  

The Brooklyn Hospital Center

 

 

 

 

 

 

 

 

 

ACPE UAN 0042-0000-26-018-L01-P

Available Credit

  • 1.00 ACPE
    The Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

You will need a device that allows you to hear and see the presentation. Some phones may have limited functionality.